Timo Karvinen joined Medaffcon’s Market Access team as an expert in the beginning of May. He holds wide-ranging experience in the pharmaceutical industry for ca. 30 years. In addition to his extensive expertise, he also brings a whole new service concept to Medaffcon.
Karvinen joined Medaffcon from its parent company Tamro, where he worked since 2019. At Tamro, he developed a new Patient Dynamics concept that he now brought along to Medaffcon and the Market Access team.
Patient Dynamics service concept constitutes, simply put, a patient analysis. It is based on Kela’s data on the number of patients receiving reimbursement.
According to Karvinen, patient data is of help, for example, when a pharmaceutical company considers how to position its product in the treatment path compared to competitors’ products. At the same time, the company can assess the user potential of the medicine.
Information can be collected on whether the product is the primary medicine in the treatment path or if it appears later, which medicines are changed and which indications patients taking a certain medicine have.
“Many pharmaceuticals are taken for several different indications and the analysis helps in finding out all the indications for which physicians prescribe a certain medicine. At the same time, one can assess adherence and how many new patients will appear”, states Karvinen.
Patient Dynamics service concept is only one part of Karvinen’s work at Medaffcon. In addition to it, his area of responsibility covers key Market Access tasks, such as the preparation of pricing and reimbursability applications as well as health economic analyses.
“I would like to work on a variety of issues. I really appreciate the fact that Medaffcon has a great spirit as well as support and sparring available. I get to learn new issues and develop.”
In the pharmaceutical industry, Karvinen is excited about its significance. He accidentally entered the business, but it has taken him over.
“With my small contribution, I can influence which treatments enter the market and ensure the realisation of high-quality treatment. When talking about human health, things are important”, tells Karvinen.
Before starting at Tamro, he worked at pharmaceutical company MSD in different tasks a total of 24 years.
For Medaffcon’s customers, Karvinen aims at providing such data and analysis that helps them make the right decisions. You gain a feeling of success when the data is available and possible challenges overcome.
Market access team leader Heini Honkanen is happy of the latest recruitment.
“Timo holds excellent experience as well as wide-ranging vision and understanding of the entire industry. We gained a top talent”, states Honkanen gratefully.
Are you employed in the pharmaceutical industry and seeking insights into your product's position within the Finnish market? Then Patient Dynamics is the ideal tool for you. Developed by Medaffcon, Patient Dynamics caters to the needs of pharmaceutical companies by providing precise information for sales and marketing decision-making.
“Renewable drug therapy challenges the current complex drug evaluation system,” states Lauri Pelkonen, a leading expert at the Ministry of Social Affairs and Health (STM). For this reason, the evaluation activity is being reformed to better respond to changes in the operating environment.
Coming up soon, Copenhagen will be the center of health economics as more than five thousand pharmaceutical and healthcare professionals gather for the ISPOR conference. ISPOR has been well known, especially among health economists. However, this years’ top trends real-world data (RWD) and real-world evidence (RWE) attract even wider audience.
Market Access Specialist & Analyst
MSc (Food Science)
Timo started at Medaffcon in May 2023, bringing his experience and know-how e.g. about developing and utilizing analyses. Timo’s long experience in pharma industry in analytics, marketing and sales gives him a good understanding of the operation of pharmaceutical companies. Timo holds a MSc in Food Economics and Marketing. Market Access and Health economic analyses are new development areas for Timo. In his previous role Timo developed analytical services for pharmaceutical companies.
Timo is inspired about supporting and helping decision making with data. “Data provides a solid foundation for decisions. Data acquired and analyses carried out should be grounded on the decisions made based on them.” Developing new things and overcoming challenges gives Timo energy at work.
Timo believes, that in the future data will be collected and combined from more sources than before. Evaluating effectiveness will be important in decision making in health care and more comprehensive health economic analyses will be needed.